FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab

Cosman, Felicia; Crittenden, Daria B; Ferrari, Serge Livio; Khan, Aliya; Lane, Nancy E; Lippuner, Kurt; Matsumoto, Toshio; Milmont, Cassandra E; Libanati, Cesar; Grauer, Andreas

doi:10.1002/jbmr.3427

Scientific article

English

FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab

ContributorsCosman, Felicia; Crittenden, Daria B; Ferrari, Serge Livio; Khan, Aliya; Lane, Nancy E; Lippuner, Kurt; Matsumoto, Toshio; Milmont, Cassandra E; Libanati, Cesar; Grauer, Andreas

Published inJournal of Bone and Mineral Research, vol. 33, no. 7, p. 1219-1226

Publication date2018

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Génétique des ostéoporoses (544)

Citation (ISO format)

COSMAN, Felicia et al. FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. In: Journal of Bone and Mineral Research, 2018, vol. 33, n° 7, p. 1219–1226. doi: 10.1002/jbmr.3427

Article (Published version)

Identifiers

PID : unige:107112
DOI : 10.1002/jbmr.3427

Journal ISSN0884-0431

446views

0downloads

Creation27/07/2018 11:39:00

First validation27/07/2018 11:39:00

Update15/03/2023 08:31:15

Status update15/03/2023 08:31:15

Last indexation31/10/2024 10:52:41

Archive ouverte UNIGE

FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab

Technical informations